CIK 0001570562
- Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 461385614
- Phone
- +1 949-284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- 4 Open-market buy 10% owner bought 115,000 shares at an average $10.63 ($1,222,137)
- 4 Open-market sale MOATAZEDI DAVID sold 70,445 shares at an average $11.13 ($783,810)
- 4 Open-market buy 10% owner bought 114,714 shares at an average $11.18 ($1,282,751)
- 4 Open-market buy 10% owner bought 65,286 shares at an average $10.87 ($709,452)
- 4/A Open-market sale Chief Marketing Officer sold 5,362 shares at $11.18 ($59,944)
- 4/A Open-market sale SILVERNAIL LAUREN P sold 14,293 shares at $11.18 ($159,774)
- 4/A Open-market sale MOATAZEDI DAVID sold 41,763 shares at $11.18 ($466,839)
- 4 Open-market sale SILVERNAIL LAUREN P sold 14,293 shares at $11.18 ($159,774)
- 4 Open-market sale Avelar Rui sold 14,293 shares at $11.18 ($159,789)
- 4 Open-market sale Chief Marketing Officer sold 5,362 shares at $11.18 ($59,944)
- 4 Open-market sale MOATAZEDI DAVID sold 41,763 shares at $11.18 ($466,839)
- 4 Grant or award Director acquired 18,011 shares (grant or award)
- 4 Grant or award MOATAZEDI DAVID acquired 48,853 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 19,313 shares (grant or award)
- 4 Grant or award Director acquired 19,313 shares (grant or award)
- 4 Grant or award Director acquired 19,313 shares (grant or award)
- 4 Grant or award Director acquired 19,313 shares (grant or award)
Page 8 of 13 · 252 filings